All posts tagged
FDA Speeds Up the Approval Process for Bayer’s New Lymphoma Drug
Janssen Stops Phase II Trial for a Danish Blood Cancer Blockbuster
A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology
New Immunotherapy Candidate receives FDA Fast Track Designation
10 Hot European Biotechs to Observe in 2017 🚀
Sanofi Jumps into the Biosimilars Market aiming for Asia
New Private Placement to Boost the Profitable Therapeutic Antibody Market
And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!
It’s Blood Cancer Day, how is Biotech fixing it?
Infographic: The Top 8 Deadliest Cancers and Who in Biotech is Fighting Them
Dutch Leukemia Phase II Gets $1M Acceleration Funding from a Generous Charity
Biotech of the week: Vivia Biotech, the Spanish Pioneer in Personalised Medicine
Labiotech UG, All Rights Reserved -
Send this to friend